Search Results for: science tv stem cell

Teachers TV: KS3/4 Science – Stem Cell Research: The Lesson – Video

Posted: March 15, 2015 at 4:40 pm


Teachers TV: KS3/4 Science - Stem Cell Research: The Lesson
Teresa Bennett is a science teacher at Collingwood College in Camberley. In this programme she structures her lesson around the controversial issue of embryo...

By: CPD College

Go here to read the rest:
Teachers TV: KS3/4 Science - Stem Cell Research: The Lesson - Video

Posted in Stem Cell Research | Comments Off on Teachers TV: KS3/4 Science – Stem Cell Research: The Lesson – Video

The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon

Posted: October 4, 2022 at 2:32 am

Dr. Derrick Rossi Named Interim CEO

NEW YORK, Sept. 9, 2022 /PRNewswire/ -- The New York Stem Cell Foundation (NYSCF) today announced the death of its Chief Executive Officer and Co-Founder, Susan L. Solomon, on September 8th, shortly after she had stepped down as CEO, after a long battle with ovarian cancer. Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna Therapeutics, has been named Interim CEO of NYSCF.

The New York Stem Cell Foundation today announced the death of its CEO and Co-Founder, Susan L. Solomon

NYSCF is a New York-based non-profit organization that supports stem cell scientists around the world and operates the NYSCF Research Institute, the largest independent stem cell laboratory in the United States. As CEO, Ms. Solomon raised over $400M for stem cell research, helping to catalyze the field and transform the future of medical research.

"This is the end of an incredible era for NYSCF," said Dr. Roy Geronemus, Chairman of the NYSCF Board of Directors. "Susan founded this organization in 2005, and guided it for over 17 years. She imagined the impossible and made it happen. I speak on behalf of the entire Board when I say that we will forever be grateful for all she did for NYSCF and for the field of stem cell research to advance better treatments and cures for patients everywhere. We are confident that Dr. Rossi as Interim CEO, and the rest of the NYSCF team, will continue the trajectory that Susan led us on to move NYSCF's mission forward.The Board has begun a search for a permanent CEO."

A lawyer by training and a longtime entrepreneur and business executive, Ms. Solomon began her role as a health-care advocate in 1992 when one of her sons was diagnosed with type 1 diabetes. After conversations with clinicians and scientists, she identified stem cells as the most promising way to address unmet patient needs and felt an independent organization was needed to help translate cutting-edge stem cell research into clinical breakthroughs and cures for patients. She co-founded NYSCF in 2005. Since then, advances from NYSCF research have twice been named Time magazine's #1 scientific breakthrough of the year, and NYSCF-supported research has led to over 20 major clinical breakthroughs that are already or very soon bringing clinical treatments for devastating diseases. During her time as CEO, Ms. Solomon served on many Boards, including the College Diabetes Network and the Regional Plan Association, and received numerous awards, including the New York State Women of Excellence Award from the Governor of New York, the Triumph Award from the Brooke Ellison Foundation, and recognition as a Living Landmark from the New York Landmarks Conservancy.

During a meeting earlier in the week with NYSCF staff to announce the CEO transition, Ms. Solomon relayed the following message:

"Building NYSCF has been the privilege of a lifetime and I am incredibly proud of the contributions we have made to the field of stem cell research and developing new and more effective treatments and cures to improving the lives of patients. I am confident that our outstanding and dedicated leadership and staff will continue to move our programs forward under Derrick's leadership and that of our longtime COO/CFO Jeff Wallerstein while the Board conducts a search for my successor."

"It has been a great privilege to serve on the NYSCF Board of Directors and I am honored to now serve as Interim CEO," said Dr. Rossi. "Since I first met Susan in 2010 and became a member of the NYSCF community, I have been in awe. Susan was a force of nature, a fierce and effective advocate for science and patients, and a true visionary. She was also a dear friend. Without question, Susan's and NYSCF's impact on science has been enormous and, quite frankly, unmatched.Though I wish that Susan could have continued her incredible and effective leadership of NYSCF for the next hundred years, I am nonetheless honored and ready to lead NYSCF over the coming months as we search for a permanent leader."

Dr. Rossi, a biotechnology entrepreneur and stem cell scientist, is the co-founder of Moderna Therapeutics, and co-founder of Intellia Therapeutics, Magenta Therapeutics, and Stelexis Therapeutics. Until his retirement from academia, he was an Associate Professor at Harvard Medical School and Harvard University, and an investigator at Boston Children's Hospital where he led an academic team working on stem cell biology and regenerative medicine. In 2010, Derrick was named a NYSCF Robertson Stem Cell Investigator and he joined the Board of Directors in 2020. His efforts in the development of cutting-edge technologies and new therapeutic strategies are at the forefront of regenerative medicine and biotechnology. Time magazine named Dr. Rossi as one of the 100 Most Influential People in the world (Time 100) in 2011. Dr. Rossi earned his B.Sc. and M.Sc. from University of Toronto, and his PhD from the University of Helsinki.

Prior to founding NYSCF, Ms. Solomon had a diverse career spanning many decades. After graduating from New York University, she received her JD from Rutgers University School of Law while raising her eldest son as a single mother and serving as an editor of the Law Review. She began her career as an attorney at Debevoise & Plimpton. The work she was most passionate about was her pro bono work, including the representation of a woman suing the NYC Fire Department for sexual discrimination based on the firefighting qualification testing that was biased toward male applicants.

She later continued her law career as counsel for Warner Amex Satellite Entertainment Corporation, a joint venture in the then-new industry of cable television to develop television networks, including MTV, Nickelodeon, and Showtime.

After jobs at United Satellite Entertainment and CBS Productions, a film arm of CBS, Ms. Solomon joined MacAndrews & Forbes to help in the area of media acquisitions, and later APAX, formerly MMG Patricof and Company, another financial firm.

Ms. Solomon subsequently joined Sony Corporation to establish and serve as President of a new radio network, Sony Worldwide Networks, which was the first to do internet radio broadcasting. She then moved on to her last media job as the founding CEO of Sothebys.com, where she helped to develop the first online auction platform.

Prior to founding NYSCF in 2005, she started her own strategic management consulting firm, Solomon Partners LLC, through which she worked with a range of non-profit and media companies.

Ms. Solomon is survived by her husband Paul Goldberger and three sons and daughters-in-law, Adam and Delphine Hirsh, Ben Goldberger and Melissa Rothberg, and Alex Goldberger and Carolyna De Laurentiis, and six grandchildren Thibeaux and Josephine Hirsh, Julian and Gabriel Goldberger, and Arlo and Celeste Goldberger.

About The New York Stem Cell Foundation Research Institute

The New York Stem Cell Foundation (NYSCF) Research Institute is an independent non-profit organization accelerating cures and better treatments for patients through stem cell research. The NYSCF global community includes over 200 researchers at leading institutions worldwide, including the NYSCF Druckenmiller Fellows, the NYSCF Robertson Investigators, the NYSCF Robertson Stem Cell Prize Recipients, and NYSCF Research Institute scientists and engineers. The NYSCF Research Institute is an acknowledged world leader in stem cell research and in the development of pioneering stem cell technologies, including the NYSCF Global Stem Cell Array, which is used to create cell lines for laboratories around the globe. NYSCF focuses on translational research in an accelerator model designed to overcome barriers that slow discovery and replace silos with collaboration.

David McKeon212-365-7440[emailprotected]

SOURCE The New York Stem Cell Foundation

Excerpt from:
The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon

Posted in New York Stem Cells | Comments Off on The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon

4 to be inducted into UK Equine Research Hall of Fame – WTVQ

Posted: September 16, 2022 at 2:34 am

LEXINGTON, Ky. (WTVQ) Four will be inducted into the Equine Research Hall of Fame, the University of Kentucky Gluck Equine Research Center announced Wednesday.

The induction honors achievements in equine research and those who have made a lasting tribute to equine health. The induction will be held on Wednesday, Oct. 26 at Kroger Field for Lisa Fortier, Katrin Hinrichs, Jennifer Anne Mumford and Stephen M. Reed.

The following achievements were provided via a press release:

Lisa Fortier

Over the past 30 years, Fortier has garnered an international reputation for significant contributions in equine joint disease, cartilage biology and regenerative medicine. She has focused her research on early diagnosis and treatment of equine orthopedic injuries to prevent permanent damage to joints and tendons. She is perhaps best known for her work in regenerative medicine, pioneering the use of biologics such as platelet-rich plasma, bone marrow concentrate and stem cells for use in horses and humans. Fortiers lab has also been instrumental in breakthroughs related to cartilage damage diagnosis and clinical orthopedic work. A testament to her impact is that 87% of U.S. equine veterinarians now use biologics for regenerative medicine in their equine patients.

Fortier earned her bachelors degree and doctor of veterinary medicine degree from Colorado State University. She completed her residency at Cornell, where she also earned a Ph.D. and was a postdoctoral fellow in pharmacology. She now holds the James Law Professor of Surgery position at Cornells College of Veterinary Medicine. She is the editor-in-chief of the Journal of the American Veterinary Medical Association and serves on the Horseracing Integrity and Safety Authority Racetrack Safety Standing Committee.

Katrin Hinrichs

Hinrichs devotes her career to research primarily in equine reproductive physiology and assisted reproduction techniques. Specifically, her focus has included equine endocrinology, oocyte maturation, fertilization, sperm capacitation and their application to assisted reproduction techniques.

Hinrichs 40 years of research have led to several significant basic and applied research achievements. The applied accomplishments include producing the first cloned horse in North America and developing the medical standard for effective intracytoplasmic sperm injection and in vitro culture for embryo production in horses. She has mentored more than 85 veterinary students, residents, graduate students and postdoctoral fellows in basic and applied veterinary research. Her laboratories have hosted approximately 50 visiting scholars from throughout the world.

Hinrichs earned her bachelors degree and doctor of veterinary medicine degree from the University of California, Davis. She completed residency training in large animal reproduction at the University of Pennsylvanias New Bolton Center and earned a Ph.D. at the University of Pennsylvania.

Jennifer Anne Mumford

A posthumous inductee, Mumford earned international respect as one of the most prominent researchers of equine infectious diseases, in particular equine viral diseases. Her distinguished career at the Animal Health Trust, Newmarket, United Kingdom, began when she became the first head of the newly established equine virology unit. Her work focused on the leading causes of acute infectious respiratory disease in the horse, primarily equine herpesvirus and equine influenza virus, and to a lesser extent,Streptococcus equi, the causative agent of equine strangles.

Mumford made numerous significant contributions in these areas, including developing improved vaccines, diagnostics and international surveillance. She also helped establish research groups in the related fields of equine genetics and immunology.

During Mumfords more than 30 year-career, she established the Animal Health Trust as one of the worlds leading centers for the study of the biology, epidemiology, immunology and pathology of diseases, including equine herpes rhinopneumonitis and equine influenza, as well as bacterial diseases, including Streptococcus and Clostridium.

Stephen M. Reed

Reeds nominators credited him as the last word in equine neurology. Reed is widely recognized as one of the most prominent equine neurologists worldwide. His list of 180 peer-reviewed publications includes significant contributions to equine medicine, neurology, physiology and pathophysiology, and has earned him worldwide recognition throughout the equine community. He has shared in his achievements as a mentor and role-model for hundreds of aspiring equine practitioners.

One of the most unique and refreshing things about Dr. Reed is he absolutely embodies the need and overlap of discovery science with clinical assessments to further our understanding of equine neurologic disease, wrote Jennifer Janes, associate professor of veterinary pathology at the UK Veterinary Diagnostic Laboratory, in her letter of support for the nomination. This mission has served as the foundation and pillars of his long career in equine veterinary medicine.

Reed earned his bachelors degree and doctor of veterinary medicine degree from The Ohio State University. He completed internship and residency training in large animal medicine at Michigan State University.

Read the rest here:
4 to be inducted into UK Equine Research Hall of Fame - WTVQ

Posted in Regenerative Medicine | Comments Off on 4 to be inducted into UK Equine Research Hall of Fame – WTVQ

Overcoming Cancer with CAR-T Cell Therapy – Gilead Sciences

Posted: August 5, 2022 at 2:22 am

Creating Possible

Stories@Gilead - August 04, 2022

In February 2019, Eleonora was preparing to go out with a friend when she suddenly fainted. She woke up in the hospital near her home in Italy and didnt remember a thing. But she will never forget the news the doctors delivered to her.

They did a CT scan and it lit up like a Christmas tree, recalls Eleonora. They found several large tumors and told me I had non-Hodgkin lymphoma.

After losing her father to cancer a year earlier, she knew she had to overcome the cancer to spare her family any more pain.

She started chemotherapy, and a CT scan later revealed that the tumor had not responded to initial lines of treatment. During that moment of discouragement, a small voice rose inside of her saying, Do not give up.

A hospital in Genoa offered Eleonora another round of chemotherapy, but she decided not to pursue it. Instead, she was inspired after watching a program on a Swiss TV channel where they discussed a form of therapy that uses the bodys own immune system to fight cancer: chimeric antigen receptor (CAR) T-cell therapy.

A whole series of lights went off in my head that this might be my solution, Eleonora says.

She contacted a lymphoma specialist to discuss her options and started CAR T-cell therapy in December 2019. Two months later, she had a follow-up PET scan and it showed she had responded to treatment, with no evidence of cancer cells showing up in the scan.

Im not talking about months anymore, instead Im talking about a life ahead of me.

Watch the video above to see Eleonoras full journey.

See the article here:
Overcoming Cancer with CAR-T Cell Therapy - Gilead Sciences

Posted in Cell Therapy | Comments Off on Overcoming Cancer with CAR-T Cell Therapy – Gilead Sciences

Top Cell and Gene therapy-2022

Posted: June 22, 2022 at 1:56 am

About Conference

Cell gene therapy 2022takes intense pleasure and honour in welcoming you all forInternational Conference on Cell and Gene Therapyduring June 27-28, 2022 atLondon, UK. Prominent keynote speakers, plenary speeches, young research forum, poster presentations, technical workshops and career guidance sessions are involved in the conference.

The conference focusses with an exciting Theme on Exploring the advancements in Cell and Gene Therapy.This scientific session offers a great platform with its well defined scientific sessions to the audience to share and express their innovative ideas on topics like Gene Therapy, Cell Therapy, Immunotherapy, Biomarkers, Stem cell in Gene therapy, Genomics, Tissue Science and Regenerative medicine, Viral Gene therapy, Epigenetics, Proteomics, Genome Editing, Nanotherapy, Advanced Gene Therapeutics and much more .

Significance of Cell and Gene Therapy Conference:

Celland gene TherapyConferences is enhance propelsmethodsand presentationof recentimprovement to the revelation of advances in Cell andgenetic field and Genetherapyis usefulin inadequate qualitiesresponsiblefor treatment of diseases usingadvancement and Cellular Therapieswhich is efficaciousto deliver Regenerative Cells and aides in quality in Cellular development of Tissues.

Cellgene Therapy2022 provides aUniversal Platformto fulfilandprovideinnovative researchon Novel andfuturemethodologies in assuaging infectionsand provides combination of Researchers, Geneticist, Biologists ,Business Delegates of Specificcompaniesand Scientiststo fulfilandprovideconcerningrecentstrategiesand Advances onthe variouscircle. Cellgene Therapy2019 Conferences main concentration is uniting Scientists, Physicians, Internationalmixof driving Universities, Celltherapy institutionsto share their examination valuable for restoring of Genet, diseasesandfacilitatein approaches for newstrategies through our Conference.

Cellgene Therapy 2022canaddress keyproblemsregardingdiseaseviewpoints in Genetic and Hereditary malady andencouragesin achieving learningreceptiveto society.

Target Audience:

Track :1 .Cell and gene therapy

Quality treatment is portrayed as a course of action of approaches that modify the announcement of a man's characteristics or repair abnormal characteristics. Each framework incorporates the association of a specific nucleic destructive (DNA or RNA). Nucleic acids are consistently not taken up by cells, subsequently exceptional transporters; implied 'vectors' are required. Vectors can be of either prominent or non-viral nature however Cell treatment is described as the association of living whole cells into the patient for the treatment of a disease. The start of the cells can be from a comparative individual (autologous source) or from another individual (allogeneic source). Youthful microorganisms are associated concerning bone marrow transplantation particularly. Diverse systems incorporate the utilization of practically create cells, isolated in vitro (in a dish) from foundational microorganisms.

Track :2 Cell damage and adoption

Cell harm can happen because of cell damage, and cell damage can additionally happen because of progress in cell's condition because of outside or inward boosts. At the point when a cell couldn't adjust and repair itself to this evolving condition, cell demise happens. Cell demise is of 2 composes Apoptosis (Programmed Cell passing) and Necrosis (Cell demise because of damage).

Track : 3. Markets and future prospects for gene therapy

The enormous number of associations related with cell treatment has extended development incredibly in the midst of the past couple of years. In excess of 500 associations have been recognized to be locked in with cell treatment and 305 of these are profiled 291 co-tasks. Of these associations, 170 are related with foundational microorganisms. The Profiles of 72 academic establishments in the US related with cell treatment close by their business facilitated endeavors. Allogeneic development with in excess of 350 clinical preliminaries is prepared to charge the commercialization of cell medicines in publicize. Progress R&D in cell and quality treatment is depended upon to bloom given the normally based purposes of intrigue.

Track: 4.Cell science research

Research in Cell Science thinks about cells their structure, physiological properties, the organelles they contain, their life cycle, division, end and cell work interchanges with their condition.

Track: 5.Molecular basis of Epigenetics

Epigenetics alludes to changes amid a body that has effect on cistron movement and articulation. It's furthermore acclimated portray any inheritable constitution alteration that does not get from a change of the body proportionate to prions. Epigenetics is that the instrument for putting away and sustaining or proceeded with uncertainly a "memory" at the cell level. Body substance might be a dynamic structure that incorporates presumably numerous signs from the cell surface and has impacts of facilitated and satisfactory transcriptional reaction in cell. It's more unmistakably that epigenetic stamping of body substance and polymer itself is an essential piece of the phone flag joining of whole works that is performed by the request. Besides, the progressions inside the epigenetic condition of body substance in cell will effectsly affect movement changes.

Track :6 Cell and gene therapy for rare common diseases

Gene therapy is a superior method to treat uncommon hereditary maladies; fix a solitary quality deformity by presenting a 'right' quality. The main quality treatment preliminaries were directed utilizing patients with uncommon monogenetic issue, however these are presently dwarfed by the clinical testing of quality therapeutics for more typical conditions, for example, malignancy, AIDS and cardiovascular illness. This is halfway because of an inability to accomplish long haul quality articulation with early vector frameworks, a basic prerequisite for amending numerous innate hereditary deformities. Presently, with the appearance of adeno-related viral (AAV) and lent viral vectors, which show steady quality articulation in creature thinks about, this mechanical obstruction, may have been survived. These vectors are foreseen to shape the premise of numerous gene therapy protocols for acquired hereditary illnesses.

Track :7 Tissue engineering and Biomaterials

Tissue Engineering might be an arrangement of techniques that may supplant or repair broken or morbid tissues with common, manufactured, or manufactured tissue emulates. These mirrors will either be absolutely down to earth or can develop into the coveted common sense. Biomaterials assume relate fundamental part in prescription todayre-establishing work and encouraging mending for people when damage or disease. Biomaterials are additionally regular or counterfeit and used in utilized in medicinal applications to help, improve, or supplant broken tissue or an organic work in different dental fields.

Track :8 Regerative Medicine

Regenerative Medicine suggests a social affair of biomedical approaches to manage investigate and clinical applications which are away to supplant or "recouping" human cells, tissues or organs to restore or set up standard limits which were vexed in view of afflictions. The field of Regenerative medication has pulled in much thought as it holds the certification of recouping hurt tissues and organs in the body by supplanting hurt tissue or by stimulating the body's own particular repair segments to retouch hurt tissues or organs. It moreover may enable scientists to create tissues and organs in the lab and safely insert them inside the body. Regenerative game plans subsequently can be a dynamic progress in the field of therapeutic administrations.

Track: 9 Cell therapy and cardiovascular disorders

Cardiovascular diseases have transformed into an extending clinical issue all around. Another test in the treatment of the cardiovascular disease is cell transplantation or cell cardiomyoplasty. Extreme ischaemic harm and relentless cardiomyopathies provoke ceaseless loss of cardiovascular tissue and in the end heart frustration. Force medications wide mean to contract the over the top changes that happen when harm and to scale back possibility segments of vas ailments. Regardless, they don't upgrade the patient's close to home fulfilment or the figure more than coordinate. Unmistakable sorts of undifferentiated living beings have been used for foundational microorganism treatment.

Track: 10 Nanotechnology in Stemcells

As of late, the entomb intersection of nanotechnology in undeveloped cell science and biomedicine has prompted a developing new research field, known as undifferentiated organism nanotechnology. Immature microorganism nanotechnology is characterized as the use of nanotechnology in undifferentiated organisms innovative work, and it is described as profoundly fast being developed, exceedingly interdisciplinary, and very disputable.

Track: 11 Stem Cell therapy

Stem Cell therapy treatment is a sort of treatment wherein undeveloped cell are utilized particularly to keep a specific malady. Undeveloped cells these days have been progressively utilized for the treatment of neurological issue, cardiovascular clutters, and numerous others. On-going investigations are continuing for the treatment of Spinal rope damage also. Hence, Stem cell treatment has an incredible breadth in future also.

Track: 12 Viral gene therapy

Customary methods for quality treatment fuse transfection. It twisted up evidently inefficient and confined fundamentally in light of transport of value into at present duplicating cells invitro. Quality treatment utilizes the transport of DNA into cells by techniques for vectors, for instance, natural nanoparticles or viral vectors and non-viral methodologies. The Several sorts of diseases vectors used as a piece of value treatment are retrovirus, adenovirus, adeno-related contamination and herpes simplex contamination. While other recombinant viral vector structures have been delivered, retroviral vectors remain the most surely understood vector system for quality treatment traditions and most prominent application in view of their undeniable significance as the essential vectors made for powerful quality treatment application and the soonest phases of the field of value treatment.

Track: 13 Gene editing and CRISPR based technologies

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Technology is a champion among the most proficient yet clear mechanical assembly for genome adjusting. It urges and empowers experts to easily change DNA groupings and modify quality limits. It has various potential applications that join helping innate diffuses, treating and keeping the spread of diseases and upgrading crops. CRISPR broadly used as CRISPR-Cas9 where CRISPRs are particular reaches out of DNA and Cas9 is the protein which is an exacerbate that shows like a few nuclear scissors, fit for cutting DNA strands. The certification of CRISPR advancement anyway raises moral stresses as it isn't 100% powerful. Regardless, the progression of CRISPR-Cas9 has vexed the designed science industry nowadays, being a direct and great quality modifying mechanical assembly.

Track: 14 Regularity and safty aspects of cell gene therapy

Cell treatment things require a grouping of prosperity considerations. Undifferentiated living being and quality things are heterogeneous substances. There are a couple of zones that particularly ought to be tended to as it is extremely not the same as that of pharmaceuticals. These range from making bunch consistency, thing soundness to thing prosperity, quality and sufficiency through pre-clinical, clinical examinations and exhibiting endorsement. This review traces the present headings/manages in US, EU, India, and the related challenges in making SCBP with complement on clinical edge.

Track: 15 Markets and future prospects for Cell and gene therapy

The gigantic number of associations related with cell treatment has extended development incredibly in the midst of the past couple of years. In excess of 500 associations have been recognized to be locked in with cell treatment and 305 of these are profiled 291 co-tasks. Of these associations, 170 are related with foundational microorganisms. The Profiles of 72 academic establishments in the US related with cell treatment close by their business composed endeavors. Allogeneic development with in excess of 350 clinical preliminaries is prepared to charge the commercialization of cell medicines in promote. Progress R&D in cell and quality treatment is depended upon to bloom given the normally based purposes of intrigue.

Track: 16 Gene therapy for diseases

Gene therapy is the addition of particular qualities at some particular destinations into a person's cells or tissues to treat a malady, in which the faulty or non-working quality is then supplanted with the working gene.

Track:17 Cellbiology

Cell science is the investigation of cell and how the cell capacities. Cell comprise of numerous organelles that perform particular capacities and assume an imperative part in the development and advancement of a living being. Cells are of 2 writes Prokaryotic Cell and Eukaryotic Cell. Case of a Prokaryotic Cell incorporates, Bacteria, then again Animal Cell and Plant Cell are described as Eukaryotic Cells.

Track:18 Nucleotide based vaccines

Recent advances effectively prescribe that educational RNA rather than DNA will be the ester reason for a substitution classification of antibodies and medications in advertise. Nucleotide-based immunizations connected to a vast fluctuate of irresistible and threatening illnesses. We tend to focus on late routes intended to support their work and exactness. We tend to are concentring on new ways and investigate figure future advancements that may bring about the essential achievement of macromolecule immunizations inside the bar and treatment of human unwellness.

Track:19 Cancer cells and Biomarkers

Malignancy cells Integrated from Healthy cells from multiple points of view that Access them to become out of administration and move toward becoming Metastasis. One imperative refinement is that growth cells territory unit less specific than conventional cells. That is, while customary cells develop into frightfully particular cell assortments with particular capacities, disease cells don't. This is regularly one reason that, as opposed to customary cells, growth cells still separation no end. Incidentally, willcer cells can initiate close conventional cells to make veins that furnish tumors with O and supplements that they need to develop. These veins conjointly take away waste item from tumors. Biomarkers region unit particles that demonstrate customary or unusual technique occurring in your body and will be an indication of partner degree fundamental condition or sickness. Various sorts of atoms acknowledge deoxyribonucleic corrosive (qualities), proteins or hormones, will work biomarkers, since every one of them show one thing in regards to your wellbeing. Biomarkers could likewise be made by the disease tissue itself or by elective cells inside the body because of malignancy.

Track:20 Genetics and Genomic medicine

Hereditary qualities are that the branch of science required with qualities, heredity, and variety in living life forms. It looks to get a handle on the strategy for ascribe legacy from oldsters to posterity, and also the sub-atomic structure and execution of qualities, succession conduct inside the setting of a cell or living being (e.g. predominance and epigenetics), cistron circulation, and variety and adjust in populaces.Genomic drugs, by and large also conjointly redid drugs, might be on account of alter restorative guide to your body's unmistakable hereditary cosmetics. Everything about cells inside the body contains deoxyribonucleic corrosive, the particles you acquire from your people that confirm anyway your body appearance and capacities. Deoxyribonucleic corrosive is composed kind of a wound stepping stool, with information keep inside the course of action, or succession, of the rungs. Segments of the polymer step that contain information required to shape proteins are alluded to as qualities. The entire structure is that the request. A practically total guide of the polymer arrangement was finished in 2003, and from that point forward, researchers have attempted to get a handle on anyway every factor capacities and the way it's planned with every elective factor. The human request may contain 20 000 to 23 000 qualities.

Cell gene therapy 2022 cordially invites you all to join us on International Conference on Cell and Gene Therapy scheduled during June 27-28, 2022 at London, UK. The conference was taking place under the theme on Exploring the advancements in Cell and Gene Therapy.

For more details:https://genetherapy.geneticconferences.com/

Scope: Scope of the meeting isto assembleeach oneof the Doctors, Researchers, Business Delegates and Scientists to approach and conveyeach oneof the participantsregardingthe premiercurrentlogical headways.It is thevariable circle or associated logical controls .This Cell and succession treatment Conference is thatthe topknowledgeunderstanding individual and structure conduct and basic leadership withrelevancescience examination andbioscience, biotechnology,pharmaceuticals, medicals andother areas.

Importance: Gathering on Cell therapeutic carecan bea bottomless praised meeting thatessentiallymanagesthe foremost current investigationand enhancementswithinthe circle of Cell andnatural science. This Conferencewillprovides a excellentstage to any or all the Internationalmixof driving investigation understudies, and Scientists accomplished distinction in their field of study, examination academicians fromthe universitiesand investigation foundations, mechanical examinationspecialistsand business connectsalong sidepHscaled. Understudies tocome backand educateeach oneof the participants withreference tothe most recentlogical headways on the few circles.

Why London???

Londonis the stunning capital city of UK, and is one of the most charismatic and vibrant cities of United kingdom. It is a city that effortlessly blends traditional heritage, with striking modernism and progressive thinking.As a holiday destination,Londonoffers a rich and varied history, a buzzing nightlife and is blessed with a glorious year-round climate.Londonis a bustling and exciting city, that boasts a wide choice of activities and fascinating tourist attractions. The city has a welcoming and liberal atmosphere, while still embracing its deep-rooted heritage and extensive history. Lisbon will appeal to a diverse selection of ages and tourists; it can form a cultural trip, a nightlife extravaganza, a family holiday, a relaxed city-break or even as a base for a beach holiday. Lisbon has hot dry summers, pleasant springs and autumns, and mild, but possibly wet winters. The best time of year to visitLondonis in the late spring (May-June) when the days are bright and sunny, but the temperatures are not so high. The peak season is between June and August, and if you visit at this time of year, you should expect the city to feel crowded. The weather is suitable for spending time on the beach from May until the end of September.

Global Cell Therapy Market:

Cellmedicinalguide item, that region unit got fromdedifferentiatedcells, tissues, and organs develop in labs, region unit infused into patients. The developing assortment of clinical preliminaries, government and individualfinance, andincreasingscope of associations betweencorporationsterritory unit driving the extension ofthe globecell restorative guide advertise. "Cell and Sequence restorative guide item that region unitofferedwithinthe market depends onautologousand allogeneic cells. Theraiseof cell treatment isincreasing."

Quality restorative guide includesconnectionofanengineeredor amodifiedsuccession misusemodified irresistible operator vectors that encourage convey the grouping atimplicitsiteof activityor evenexecute the cellwhich cancause thedisease. This treatment is forthe foremostparta one-time treatment orwantssimplyfew measurements of prescription tofullyfix thedisease.

The examiners estimatethe globecell therapeutic guide market to develop at a CAGR of9.5%duringtheyear 2019-2026. The report coversthisscenarioandonthese linesthe eventprospects ofthe globecell therapeutic guidebusinesscenter for 2019-2026. The report introducesa close-byimageof the market bystrategiesfor study, blend, and summationof informationfromvariedsources.

Top Universities around the Globe

Statistical Analysis of universities

List of Companies Associated with Cell and Gene Therapy Research

Top Major Societies Associated with Cell and Gene Therapy

Pie Chart between Companies and Societies associated

Market Value on Cell and Gene Therapy

Genemedical caremay be aattractiveareafor drug development as aresult ofwiththe propertarget and approach;it willaddressthe premisereason for a severemalady.Evidentlydisorderswhereacknowledged genetic mutationsas a result ofdeficient or non-functionalmoleculeproduction, sequencemedical carecanfix the underlying defectand providea pathto producethe sensiblemolecule.

The worldwide sequencemedical caremarket was valued at $584 million in 2016, and isdeterminabletoreach$4,402 million by 2023, registering a CAGR of33.3% from 2017 to 2023.the increasein funding for R&D activitiesreferring tosequencemedical careand increase in awarenessregardingsequencemedical aidunitthe foremostvitalfactors that drive the market growth.

See more here:
Top Cell and Gene therapy-2022

Posted in Cell Therapy | Comments Off on Top Cell and Gene therapy-2022

Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline – Bloomingprairieonline

Posted: April 19, 2022 at 2:31 am

Stem cell characterization kitst Market sizeis done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis.

Bottom-up approach is always used to obtain Stem cell characterization kits insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level.

Market Overview:-

Stem cells are biological cells that can be converted into specific type of cells as per the bodys requirement. Stem cells are of two types, i.e., adult stem cells and embryonic stem cells. Stem cells can be used to treat various diseases such as cancer, neurodegenerative disorder, cardiovascular disorder and tissue regeneration. Stem cell characterization is the initial step for stem cell research.

Stem cell characterization kit is required to understand the utility of the stem cells in downstream experiments and to confirm the pluripotency of the stem cell.The growth of the stem cell characterization kits market is expected to be being fuelled by government funding for stem cell research.

To Remain Ahead Of Your Competitors, Request for Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=2691

Fact.MR, a leading authority on market research brings original, in-depth, and insightful reports to investors On Stem Cell Characterization Kits Market Sales & Demand. Fact.MRs report will highlight various growth forecasts, key trends, and notable segments ripe for upcoming investments.

Key Parameters analyzed while estimating the Stem Cell Characterization Kits market include:

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts to arrive at various estimations and projections for Sales & Demand of Stem Cell Characterization Kits, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

SWOT analysis has been performed in the Sales study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels

Company share analysis is used to derive the size of the global Stem Cell Characterization Kits market. As well as a study of the revenues of companies for the last several years also provides the base for forecasting the market size and its Sales growth rate.

This study offers an overview of the existing market trends, metrics, drivers, and restrictions and also offers a point of view for important segments. The report also tracks product and services demand growth forecasts for the market.

Stem Cell Characterization Kits Market Segmentation:

Based on type of stem cell, the stem cell characterization kits market is segmented into:

Based on application, the stem cell characterization kits market is segmented into:

Based on end user, the stem cell characterization kits market is segmented into:

North America and Europe are expected to witness significant growth in the global stem cell characterization kit market over the forecast period. This is owing to presence of key manufacturers and researchers of stem cell based therapies in these regions. Moreover, manufacturers such as ThermoFisher Scientific, and Becton Dickinson providing stem cell assays are present in North America region.

Asia Pacific is expected to show significant growth in the stem cell characterization kit market over the forecast period, as researchers from China and Japan are working on stem cell based therapies. For instance, in 2017, clinical trials of embryonic stem cells were launched in China for Parkinsons disease.

The Stem Cell Characterization Kits Sales study analyzes crucial trends that are currently determining the growth of Stem Cell Characterization Kits Market.

There is also to the study approach a detailed segmental review. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

The Key trends Analysis of Stem Cell Characterization Kits also provides dynamics that are responsible for influencing thefuture Sales and Demand of Stem Cell Characterization Kits marketover the forecast period.

Request Customized Report as Per Your Requirementshttps://www.factmr.com/connectus/sample?flag=RC&rep_id=2691

The report covers following Stem Cell Characterization Kits Market insights and assessment that are helpful for all participants involved in the Stem Cell Characterization Kits market:

NOTE:Our team are studying Covid19 and its impact on the Sales growth of Stem Cell Characterization Kits market and where necessary we will consider the Covid-19 footmark for better analysis of the market Demand and industries outlook. Contact us cogently for more detailed information.

Further, the Stem Cell Characterization Kits market Survey report emphasizes the adoption pattern And Demand of Stem Cell Characterization Kits Market across various industries.

The Stem Cell Characterization Kits Sales study offers a comprehensive analysis on diverse features including production capacities, Stem Cell Characterization Kits demand, product developments, Stem Cell Characterization Kits revenue generation and Stem Cell Characterization Kits Market Outlook across the globe.

Competitive Landscape Analysis On Stem Cell Characterization KitsMarket:

In this report, leading market participants involved in the manufacturing of Stem Cell Characterization Kits are covered. Analysis regarding their product portfolio, key financials such as market shares and sales, SWOT analysis and key strategies are included in this report. To provide decision-makers with credible insights on their competitive landscape, the Stem Cell Characterization Kits industry research report includes detailed market competitive landscape analysis.

Some of the key participants in the global Stem Cell Characterization Kits Market include :

Examples of some of the key participants in the stem cell characterization kits market identified across the value chain include Merck KGaA, Celprogen, Inc., Creative Bioarray, Thermo Fisher Scientific Inc., BD Biosciences, R&D Systems, Inc., System Biosciences, Cosmo Bio USA, BioCat GmbH, and DS Pharma Biomedical Co., Ltd.

Enquiry Before Buying https://www.factmr.com/connectus/sample?flag=EB&rep_id=2691

After glancing through the report on globalStem Cell Characterization Kits market Demand, readers will get valuable insight into the following:

The Survey report highlights the growth factors and entry barriers for the key players and talks about the new trends emerging in the globalStem Cell Characterization Kitsmarket.

In addition to this, the study sheds light on changing market size, revenue growth, and share of important product segments. Analysts at Fact.MR give prominent data on recent technological developments and product developments in the Stem Cell Characterization Kits Demand during the assessment period.

A comprehensive estimate on Demand of Stem Cell Characterization Kits market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Stem Cell Characterization Kits market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Market Snapshot

The rising prevalence of cancer, cardiovascular disorders and neurodegenerative diseases and the role of stem cell therapy in treating these diseases is projected to drive the growth of stem cell characterization kit market.

As per the American Cancer Society, in 2017 cancer accounted around 1 out of 4 deaths in the U.S. and was the second most common cause of deaths in the U.S.

Stem cell therapy and stem cell transplant has huge potential to treat such chronic diseases, which is expected to have a positive impact on the growth of the stem cell characterization kits market.

Stem cell transplant is useful for the treatment of spinal cord injury, stroke, and Alzheimers disease, which is expected to fuel the adoption of stem cell characterization kits over the forecast period.

The Stem Cell Agency, California, is working on the development of new stem cell-based therapies for chronic diseases such as cancer and rare diseases, where stem cell characterization kits are primarily required.

Stem cell characterization kit is also required to identify the appropriate stem cells for the treatment of -Thalassemia. Due to the increasing research and study on stem cells, the stem cell characterization kit market is expected to witness significant growth over the forecast period.

The role of stem cell characterization kit is very important because if the stem cells are not characterized properly into required adult cell type, transplanted stem cells may revert back to teratomas and there is a possibility of transplant rejection. This is expected to influence the growth of the stem cell characterization kit market.

More Related Reports By Fact.MR On Healthcare Domain :

Veterinary Endodontics MarketVeterinary Endodontics Market Forecast, Trend Analysis & Competition Tracking Global Review 202Artificial Eyes to 203Artificial Eyes

Hemorrhoids Treatment Device MarketHemorrhoids Treatment Devices Market Forecast, Trend, Analysis & Competition Tracking Global Market Insights 202Artificial Eyes to 203Artificial Eyes

About Fact.MR

Market research and consulting agency with a difference! Thats why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and well be an able research partner.

Contact:US Sales Office :11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583E-Mail:sales@factmr.com

Corporate Headquarter:Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers,Dubai, United Arab Emirates

Visit Our Website:https://www.factmr.com

Read more from the original source:
Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline - Bloomingprairieonline

Posted in California Stem Cells | Comments Off on Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline – Bloomingprairieonline

Hearing Loss Can Be Reversed With New Regenerative Therapy, Say MIT Scientists – IFLScience

Posted: April 19, 2022 at 2:00 am

If you know at least two random people, then chances are you know somebody with somedegree of hearing loss. For many of those people, its just a minor thing an annoying reason to turn the TV volume up. But for others, it candrastically impact quality of life no longer able to make out what loved ones are saying, cut off from the music and social lifethey used to enjoy, and maybe living with endless ringing and buzzing in its place.

Atherapy that could reverse hearing loss would be life-changing for millions and thats what biotechnology company Frequency Therapeutics, a spinout company from MIT, says theyve created. Not a hearing aid, not an implant, but a new drug that can give people their hearing back.

Hearing is such an important sense; it connects people to their community and cultivates a sense of identity, said Jeff Karp, Frequency Therapeutics co-founder and professor of anesthesia at Brigham and Womens Hospital, in a statement. I think the potential to restore hearing will have enormous impact on society.

So how does this potential cure for hearing loss work? Its kind of amazing: the drug stimulates progenitor cells a descendent of stem cells that live in the inner ear to start new making hair cells.

Making your ears more hirsute may not sound like the obvious cure for hearing loss, but it actually makes a lot of sense. We sometimes think of hearing as finishing when the noise hits our eardrum, but thats only half of the story: after that, the vibrations from the sound waves move on to the ossicles the three smallest bones in your body. These tiny bones are really neat: they basically act like a hammer hitting a gong thats next to a loudspeaker. Except teeny.

That loudspeaker, aka the cochlea, is where the hair cells come in. Its a hollow bone in the shape of a spiral the name actually means snail shell filled with fluid. When that fluid is moved by the vibrations from the noise, up to 15,000 hair cells in the cochlea pick it up, and theyre what finally send the signals to the auditory nerve so that we can hear the original noise.

So: no hair cells, no hearing. The problem is, those cells are very fragile they can be damaged by certain illnesses and medications, or even just too many loud noises. And once theyre gone, they dont come back.

Until now, apparently.

Some of these people [in the trials] couldnt hear for 30 years, and for the first time they said they could go into a crowded restaurant and hear what their children were saying, said co-founder and MIT Institute Professor Robert Langer. Its so meaningful to them. Obviously more needs to be done, but just the fact that you can help a small group of people is really impressive to me.

Frequency Therapeutics says theyve already given the treatment to more than 200 people, and seen significant improvements in patients hearing in three out of four clinical trials. The therapy is long-lasting hearing has been improved for nearly two years in some cases and it comes in the form of a single injection into the inner ear, making it much simpler and quicker than alternatives like gene therapy.

I wouldn't be surprised if in 10 or 15 years, because of the resources being put into this space and the incredible science being done, we can get to the point where [reversing hearing loss] would be similar to Lasik surgery, where you're in and out in an hour or two and you can completely restore your vision, Karp says. I think we'll see the same thing for hearing loss.

However,perhaps the most tantalizing aspect of this new therapy is its future potential.

Tissues throughout your body contain progenitor cells, so we see a huge range of applications, explained Frequency co-founder and Chief Scientific Officer Chris Loose. We believe this is the future of regenerative medicine.

When we were conceiving of this project, we meant for it to be a platform that could be broadly applicable to multiple tissues, added Karp.

To me its the tip of the iceberg in terms of what can be done by taking small molecules and controlling local biology.

Read the original:
Hearing Loss Can Be Reversed With New Regenerative Therapy, Say MIT Scientists - IFLScience

Posted in Regenerative Medicine | Comments Off on Hearing Loss Can Be Reversed With New Regenerative Therapy, Say MIT Scientists – IFLScience

The Global Circulating Tumor Cells (CTC) Market Will Grow to USD 18.41 Billion by 2026, at a CAGR of 14.1% – GlobeNewswire

Posted: April 6, 2022 at 2:43 am

Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Global Circulating Tumor Cells (CTC) Market (2021-2026) by Technology, Application, Product, Specimen, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Circulating Tumor Cells (CTC) Market is estimated to be USD 9.52 Bn in 2021 and is expected to reach USD 18.41 Bn by 2026, growing at a CAGR of 14.1%.

Key factors such as the growing incidence of cancer followed by the increasing potential of CTCs in diagnosis and treatment have been a prominent driver for the Global Circulating Tumor Cells (CTC) Market.

Similarly, the shifting preference towards minimally invasive diagnostic methods and higher awareness about cancer has led to preventive initiatives taken by individuals in demand for preventive medicines.

However, factors such as lack of awareness and technical difficulties in detection are likely to restrain the market growth. Moreover, stringent government regulations and reluctance to adopt novel CTC technologies are posing to cause significant challenges for the market growth.

Market Segmentation

Company Profiles

Some of the companies covered in this report are Aviva Biosciences, Advanced Cell Diagnostics, Biocept, LungLife AI, Creatv Micro Tech, Miltenyi Biotec, Menarini Silicon Biosystems, Precision for Medicine, Qiagen, etc.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary3.1 Introduction3.2 Market Size and Segmentation3.3 Market Outlook

4 Market Influencers4.1 Drivers4.1.1 Growing Incidence of Cancer and Potential Of CTC In Diagnosis and Treatment4.1.2 Increasing Demand for Preventive Medicine and Companion Diagnostics4.1.3 Increasing Preference for Non-Invasive Methods Cancer Diagnosis4.2 Restraints4.2.1 Stringent Government Regulations4.2.2 Technical Difficulties in Detection4.2.3 High Variability Among Patient Samples and Assays in Immuno-Oncology Trials4.3 Opportunities4.3.1 Increasing R&D Activities in CTC Analysis and Detection Practices4.3.2 Advancements in Chip Technology4.3.3 Emergence of New Single-Cell Technologies4.4 Challenges4.4.1 Lack Of Awareness4.4.2 Reluctance For the Adoption of Novel CTC Technologies

5 Market Analysis5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis

6 Global Circulating Tumor Cells (CTC) Market, By Technology6.1 Introduction6.2 CTC Enrichment6.2.1 Immunocapture/Label-Based6.2.1.1 Positive Selection6.2.1.2 Negative Selection6.2.2 Size-Based Separation/Label-Free6.2.2.1 Membrane-Based Size Separation (Label-Free)6.2.2.2 Microfluidic-Based Size Separation (Label-Free)6.2.3 Density-Based Separation (Label-Free)6.2.4 Combined Methods (Label-Free)6.3 CTC Direct Detection6.3.1 Microscopy6.3.2 SERS6.3.3 Immunocytochemical Technology6.3.4 Molecular (RNA)-Based Technology6.3.5 Others6.4 CTC Analysis & Downstream Assays

7 Global Circulating Tumor Cells (CTC) Market, By Application7.1 Introduction7.2 Multiple Chromosome Abnormalities7.3 RNA Profiling7.4 Protein Expression7.5 Cellular Communication

8 Global Circulating Tumor Cells (CTC) Market, By Product8.1 Introduction8.2 Devices or Systems8.3 Kits & Reagents8.4 Blood Collection Tubes

9 Global Circulating Tumor Cells (CTC) Market, By Specimen9.1 Introduction9.2 Blood9.3 Bone Marrow9.4 Other Body Fluids

10 Global Circulating Tumor Cells (CTC) Market, By End User10.1 Introduction10.2 Research & Academic Institutes10.3 Hospitals/ Clinics10.4 Diagnostic Centers

11 Global Circulating Tumor Cells (CTC) Market, By Geography11.1 Introduction

12 Competitive Landscape12.1 Competitive Quadrant12.2 Market Share Analysis12.3 Strategic Initiatives

13 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/9nffnt

Read more here:
The Global Circulating Tumor Cells (CTC) Market Will Grow to USD 18.41 Billion by 2026, at a CAGR of 14.1% - GlobeNewswire

Posted in Cell Medicine | Comments Off on The Global Circulating Tumor Cells (CTC) Market Will Grow to USD 18.41 Billion by 2026, at a CAGR of 14.1% – GlobeNewswire

World’s Third AIDS Patient Cured – WESTVIEW NEWS – WestView News

Posted: April 6, 2022 at 2:04 am

What Does it Mean for a Global Cure?

By Kambiz Shekdar, Ph.D.

Within the research community, the Holy Grail to cure AIDS had been to find new drugs to Shock and Kill the festering virus from its hiding places (latent infections and viral reservoirs). No such drugs have been developed, yet three persons have been cured using highly imaginative stem cell strategies. The most recent stem cell cure reported in February 2022 is beginning to cause the field to re-think and expand strategies to develop a global cure, including new initiatives by NIH.

HIV INFECTION. The goal of a cure for HIV is to replace human T-cells infected with HIV (left) with non-infected cells (right). Photo credit: Nancy Burson in collaboration with Kunio Nagashima.

Many readers of this newspaper will remember the height of the AIDS epidemic. New York Citys West Village, where this newspaper is based, has always been one of the epicenters of the AIDS epidemic in the United States. The neighborhoods St. Vincents Hospital, now closed, once served as the center for compassionate care of dying patients. Today, an AIDS Memorial sits adjacent to where St. Vincents once stood, as though AIDS is history. In fact, the best way we can memorialize those lost to AIDS and impact the lives and health of future generations to come all around the world is to build a research incubator and hub to accelerate a global cure, right here in New York City.

A brief timeline of 40 years of AIDS: the modern HIV epidemic started in the early 1980s. The first life-saving AIDS drug cocktail was introduced by Dr. David Ho in 1995. Global access to the drugs was initiated by President George W. Bush in 2003 via PEPFAR (Presidents Emergency Plan for AIDS Relief). In 2012, the FDA approved the use of existing AIDS medications to prevent HIV infection. AIDS may have been tamed, but it did not go away; it has been smoldering ever since.

HIV-associated neurocognitive disorders (HAND) occur in some 50% of people living with HIV. HAND is not in the least bit addressable by any of the many existing AIDS medications available today, not even in people who may achieve undetectable viral levels using existing AIDS medications. The disease continues to ravish the poorest and most disenfranchised communities, in the U.S. this started with the gays and now includes black women, our prison populations, trans individuals and our inner cities.

40 million people around the world are living with HIV, making Planet Earth a massive petri dish for the emergence of new strains. COVIDs Delta, Omicron, and Deltacron variants illustrate how infectious agents can change and evade existing defenses. So far, drug makers have been able to develop stronger and newer drugs to new strains of HIV, but this is getting more challenging all the time. Moreover, young gay men in the U.S. have largely stopped using condoms, creating ideal conditions for the spread of any drug-resistant HIV.

With treatment and prevention drugs alone, we can maintain a smoldering HIV/AIDS epidemic, but we cannot end it. With a cure, a vaccine or both, we can end AIDS for good and wipe HIV off the face of the planet.

ENTER CURE: Timothy Ray Brown is the first person cured of AIDS. Mr. Brown recounted how he was cured at a symposium at Columbia University organized by Research Foundation to Cure AIDS. He said that he suffered from both leukemia and AIDS. His physician, Dr. Gero Hutter, had an idea. Dr. Hutter was not an HIV or AIDS specialist, but he recalled from his days in medical school how certain rare individuals are naturally resistant to HIV/AIDS. Mr. Brown needed a bone marrow stem cell transplant to cure his leukemia. What if, Dr. Hutter reasoned, the stem cell transplant was sourced from a donor who is selected from the group of individuals who is naturally resistant to HIV. Could the transplanted stem cells give rise to a new HIV-resistant immune system that would cure Mr. Brown of both AIDS and leukemia? Mr. Brown was a willing guinea pig. The answer to this pairs experiment was a resounding YES!

Who was this leukemia doctor with claims of using stem cells to cure AIDS in 2007, when stem cell science was new and when almost all the experts in the field believed new drugs, not stem cells, were required to achieve a cure? Not even long-time AIDS activists popped any champagne bottles. Was this yet another case of drinking goats milk to cure AIDS? It took years for news of the innovative cure to catch.

DRIP BY MONUMENTAL DRIP, the three cures to date and the new knowledge gleaned from each success have chipped away at the calcified and crusty assumptions with the real-world data and results of what works to cure AIDS. Each of the cures and their contribution to the field of curing AIDS using innovative stem cell strategies are summarized below.

STEM CELL CURE #1, reported in 2007, used HIV resistant stem cells to cure AIDS. But because only one person was cured, it was formally possible that something else or extra about the biology or genetics of either the donor or the patient, or both, was at play. In addition, because the patient suffered from leukemia as well as AIDS, he underwent radiation to eliminate his cancerous immune system first. Also, the donor-derived stem cells that were transplanted into the patient caused a phenomenon known as GVHD (graft versus host disease) where the implanted cells attacked the recipients own cells. Any of these factors could have contributed to the cure of the patient in addition to the curative role of the HIV-resistant stem cell transplant.

STEM CELL CURE #2, reported in 2019, was achieved in much the same way as the first. Now two people were cured, not just one, providing clinical proof that the cure could be repeated and that the first case was not a fluke. Also, by this time, similar cures were attempted in additional patients who suffered with both leukemia and AIDS but using regular stem cell transplants and not HIV-resistant stem cells. All these attempted cures failed, suggesting that radiation to kill off a patients cancerous immune system without adding back HIV resistant stem cells is not sufficient to cure AIDS.

STEM CELL CURE #3, reported in 2022, makes a compelling trifecta. This third was achieved in a multiracial woman. With the first cure being that of a White man, the second that of a Latino male, and the third a multiracial woman, together, the diverse backgrounds of the three individuals cured to date dispels the possibility that any particular biology or genetics of the individuals involved was likely a key factor in achieving any of these cures. Moreover, GVHD did not take hold in patient #3, increasingly pointing to a central curative role being played by the naturally HIV resistant stem cells that were in common across all three cures to date.

Any time when the first patients are cured from a disease that has been lingering for decades, the primary goal of the research community must be to investigate all possible factors, especially all of the factors that were involved in the index cases, that could have contributed to the outcome. 15 years ago, Dr. Hutter showed us all a cure is possible. It took the NIH until the end of 2019 to make its first major announcement prioritizing the development of a global cure for AIDS. Regrettably, the COVID pandemic hit just six weeks later. Since then, I have seen one narrowly-defined call from the NIH for research proposals expressly focused on curing AIDS.

Much more can and must be done to make up for lost time and mobilize a cure. During the last 40 years of living with AIDS, the focus has been on drugs to treat and prevent HIV/AIDS. Now, the cure of three patients using stem cells points to the need to invigorate and add to the field. Room must be made to add new teams that bring novel and differentiated cellular biotechnologies needed to harness natural and curative biological resistance to HIV to develop a global cure.

For full disclosure, I am President and Founder of Research Foundation to Cure AIDS (RFTCA). RFTCA is not about treatment or prevention; were about the cure. Together with our collaboration partners at Columbia University Medical Center, New York Stem Cell Foundation, New York Blood Center and others, RFTCA has applied for NIH grant funding to advance innovate stem cell science originating from The Rockefeller University.

The imaginative and breathtaking results that Dr. Hutter demonstrated when he combined pieces of knowledge known to allbut synthesized by none before himinto a coherent sequence of events that cured AIDS for the first time ever, inspired me ever since I heard about his work. The recent news of the third patient cured of AIDS and how this cure specifically informs the field makes me more hopeful than ever about the prospects of developing a global cure.

Rockefeller University alumnus and biotech inventor Kambiz Shekdar, Ph.D., is the president of Research Foundation to Cure AIDS and Science & LGBTQ editor at WestView News. To support RFTCA, go to https://rftca.org/.

Original post:
World's Third AIDS Patient Cured - WESTVIEW NEWS - WestView News

Posted in Stem Cells | Comments Off on World’s Third AIDS Patient Cured – WESTVIEW NEWS – WestView News

Postdoc Position in Bioinformatics in Stem Cell Neurobiology job with MASARYK UNIVERSITY | 276195 – Times Higher Education (THE)

Posted: December 24, 2021 at 2:17 am

Department Department of Histology and EmbryologyFaculty of MedicineDeadline 28 Feb 2022Start date Jully 2022Job type full-timeJob field Science and research

Medical Faculty of Masaryk University, Brno, Czech Republic, invites excellent scientists to apply for

Postdoc position in Bioinformatics in Stem Cell Neurobiology

Description:

The Department of Histology and Embryology is an educational and research workplace at the Medical Faculty of Masaryk University, Brno, the Czech Republic. The Department provides courses on all aspects of normal structure and development of human tissues and organs to students of General medicine and Dentistry. The Department is recognized as premier place in the country for research mainly focusing on human pluripotent stem cells, their biology, and applications in biomedicine.

The successful candidate should:

Specific criteria for this position:

The applicant shall submit:

MU offers the opportunity to get:

Anticipated start date:The position is available from July 2022

The submission deadline is28. February 2022

How to apply:

Please use the "E-Application" link below. After submitting your application, you will receive an automatic confirmation of acceptance via email. For more information, please contact Martina Vrblkov atvrablikova@med.muni.cz.

Areview of applications will commence immediately after the deadline. Short-listed candidates will be invited for interview within one month of the deadline.

Further information about:

More:
Postdoc Position in Bioinformatics in Stem Cell Neurobiology job with MASARYK UNIVERSITY | 276195 - Times Higher Education (THE)

Posted in Stem Cells | Comments Off on Postdoc Position in Bioinformatics in Stem Cell Neurobiology job with MASARYK UNIVERSITY | 276195 – Times Higher Education (THE)